Clinical Trial Update: Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis [Phase 2]

View source ↗

Summary

This completed Phase 2 trial assessed the safety and efficacy of an anticholinergic agent for treating primary axillary hyperhidrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhidrosis

Drugs mentioned

• Anticholinergic agent

Snippet

Sponsor: Watson Pharmaceuticals | Conditions: Hyperhidrosis | Phase 2 | Status: COMPLETED